HCP
HashiCorp, Inc. Class A Common Stock
stock NASDAQ

it’s kind of more like a Claude for MDs now. their biggest recent change was adding specialized clinical AI (they bought a smaller company that used to do this pretty well) and documentation assistant scribe. they have been doing telehealth voice-over-ip for a while (not small, 300K HCP calls per day). they also have a medical news feed that gets quite a lot of traffic
seems like excitement is that there’s been a big uptick in number of MDs using their products past year (I can confirm from personal experience). they did a full rebrand around it and i have to say the quality of their AI is quite good now
moat vs. Claudes of the world seem mainly around compliance (generalist tools don’t allow doctors to enter patient info), hospital relationships (takes years to get tools approved, they have a foot in the door with VoIP) and specialized clinical workflows that aren’t well served by general purpose products
credible play imho, MD eyeballs are worth an unreal amount of $ and the AI where the doctors ask their questions is first-class real estate for targeted pharma ads. also terribly hard for others to compete against a company offering everything for free profitably

it’s kind of more like a Claude for MDs now, though that’s not exactly right either. their biggest recent change was adding specialized clinical AI (they bought a smaller company that used to do this pretty well). they have been doing telehealth voice-over-ip for a while (not small, 300K HCP calls per day). they also recently added a scribe for auto transcribing patient encounters that also links to the AI.
there’s been a big uptick in number of MDs using their AI in past year. they did a full rebrand around it.
moats seem mainly around compliance (generalist tools don’t allow doctors to enter patient info), hospital relationships (they need to approve the tools individually), and specialized clinical workflows that aren’t well served by general purpose products
it’s a credible thesis imho, MD eyeballs are worth $$$ and the AI where the doctors ask their questions is first-class real estate for targeted pharma ads

it’s kind of more like a Claude for MDs now. their biggest recent change was adding specialized clinical AI (they bought a smaller company that used to do this pretty well) and documentation assistant scribe. they have been doing telehealth voice-over-ip for a while (not small, 300K HCP calls per day). they also have a medical news feed that gets quite a lot of traffic
seems like excitement is that there’s been a big uptick in number of MDs using their products past year (I can confirm from personal experience). they did a full rebrand around it and i have to say the quality of their AI is quite good now
moat vs. Claudes of the world seem mainly around compliance (generalist tools don’t allow doctors to enter patient info), hospital relationships (takes years to get tools approved, they have a foot in the door with VoIP) and specialized clinical workflows that aren’t well served by general purpose products
credible play imho, MD eyeballs are worth an unreal amount of $ and the AI where the doctors ask their questions is first-class real estate for targeted pharma ads. also terribly hard for others to compete against a company offering everything for free profitably

it’s kind of more like a Claude for MDs now, though that’s not exactly right either. their biggest recent change was adding specialized clinical AI (they bought a smaller company that used to do this pretty well). they have been doing telehealth voice-over-ip for a while (not small, 300K HCP calls per day). they also recently added a scribe for auto transcribing patient encounters that also links to the AI.
there’s been a big uptick in number of MDs using their AI in past year. they did a full rebrand around it.
moats seem mainly around compliance (generalist tools don’t allow doctors to enter patient info), hospital relationships (they need to approve the tools individually), and specialized clinical workflows that aren’t well served by general purpose products
it’s a credible thesis imho, MD eyeballs are worth $$$ and the AI where the doctors ask their questions is first-class real estate for targeted pharma ads